158 related articles for article (PubMed ID: 2606448)
1. [Electrophysiological testing of multiple antiarrhythmic drugs in patients with paroxysmal supraventricular tachycardia after chronic oral administration].
Nishino T
Hokkaido Igaku Zasshi; 1989 Nov; 64(6):738-48. PubMed ID: 2606448
[TBL] [Abstract][Full Text] [Related]
2. [Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia].
Musto B; D'Onofrio A; Cavallaro C; Musto A; Della Gatta O; Marsico F
G Ital Cardiol; 1987 May; 17(5):444-9. PubMed ID: 3115857
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination].
Purcaro A; Capestro F; Ciampani N; Fratadocchi GB; Mazzanti M; Costantini C; Molini E
G Ital Cardiol; 1987 Aug; 17(8):690-8. PubMed ID: 3121426
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia.
Gambhir DS; Bhargava M; Arora R; Khalilullah M
Indian Heart J; 1995; 47(3):237-43. PubMed ID: 7558090
[TBL] [Abstract][Full Text] [Related]
5. [The pharmacological treatment of supraventricular atrioventricular nodal reentry or accessory pathway reentry tachycardias: the usefulness of transesophageal electrophysiological study in the selection of therapy].
Sarubbi B; Ducceschi V; Esposito R; Briglia N; Manzo G; Mayer MS; Santangelo L; Iacono A
Cardiologia; 1996 Jun; 41(6):543-9. PubMed ID: 8766417
[TBL] [Abstract][Full Text] [Related]
6. [Usefulness of transesophageal electrophysiological study during the ergometric test in the evaluation of supraventricular paroxysmal tachycardia occurring during exertion].
Delise P; D'Este D; Bonso A; Allibardi P; Raviele A; Di Pede F; Piccolo E
G Ital Cardiol; 1989 Dec; 19(12):1094-104. PubMed ID: 2576799
[TBL] [Abstract][Full Text] [Related]
7. [Effects of oral and injectable flecainide in patients with an accessory atrioventricular pathway].
Fauchier JP; Cosnay P; Rouesnel P; Moquet B; Bonnet P; Scala PJ; Demeyer JF
Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():81-90. PubMed ID: 3938264
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias.
Fujiki A; Tani M; Mizumaki K; Shimono M; Inoue H
J Cardiovasc Pharmacol; 1994 Mar; 23(3):374-8. PubMed ID: 7515979
[TBL] [Abstract][Full Text] [Related]
9. [Injectable and oral cibenzoline in the treatment of supraventricular tachycardia related to intranodal reentry or accessory atrioventricular conduction pathway].
Fauchier JP; Rouesnel P; Breuillac JC; Cosnay P; Scheck F; Garnier LF
Ann Cardiol Angeiol (Paris); 1994 Apr; 43(4):194-203. PubMed ID: 8024234
[TBL] [Abstract][Full Text] [Related]
10. Accessory pathway reciprocating tachycardia.
Obel OA; Camm AJ
Eur Heart J; 1998 May; 19 Suppl E():E13-24, E50-1. PubMed ID: 9717020
[TBL] [Abstract][Full Text] [Related]
11. [Electrophysiologic effect of a new Ca(2+)-antagonist, TA-3090 on supraventricular tachycardia and conduction system].
Tanno K; Kobayashi Y; Miyata A; Chiyoda K; Nakagawa H; Kurano K; Kikushima S; Yazawa T; Baba T; Mukai H
Kokyu To Junkan; 1992 Sep; 40(9):897-902. PubMed ID: 1439290
[TBL] [Abstract][Full Text] [Related]
12. [Catheter ablation in supraventricular tachycardia].
Pitschner HF; Neuzner J
Z Kardiol; 1996; 85 Suppl 6():45-60. PubMed ID: 9064982
[TBL] [Abstract][Full Text] [Related]
13. [Supraventricular paroxysmal reentry tachycardia. Empirical and guided therapy].
Piccolo E; Bonso A; Raviele A; Delise P
Cardiologia; 1991 Aug; 36(8 Suppl):87-97. PubMed ID: 1817777
[TBL] [Abstract][Full Text] [Related]
14. [Role of a "bystander" concealed accessory pathway in the response to verapamil and flecainide treatment in a patient with nodal reentry tachycardia].
Matteucci C; Busi G
G Ital Cardiol; 1996 Apr; 26(4):419-25. PubMed ID: 8707026
[TBL] [Abstract][Full Text] [Related]
15. [The study of acute clinical electrophysiological effects of propafenone on paroxysmal supraventricular tachycardia using transesophageal atrial pacing technique].
Li Q; Wang Z; Peng D
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(2):123-6. PubMed ID: 9868052
[TBL] [Abstract][Full Text] [Related]
16. [Exogenous adenosine as an anti-arrhythmia agent].
Tebbenjohanns J; Pfeiffer D; Schumacher B; Korte T; Jung W; Lüderitz B
Z Kardiol; 1996; 85 Suppl 6():191-9. PubMed ID: 9064965
[TBL] [Abstract][Full Text] [Related]
17. [Injectable and oral propafenone in nodal reentry and pathways of ventricular preexcitation].
Fauchier JP; Cosnay P; Moquet B; Rouesnel P; Kapusta P; Vrancea F
Arch Mal Coeur Vaiss; 1986 Sep; 79(10):1506-14. PubMed ID: 3099684
[TBL] [Abstract][Full Text] [Related]
18. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L
Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
[TBL] [Abstract][Full Text] [Related]
19. [Anti-arrhythmia and electrophysiological effects of encainide in supraventricular tachycardias].
Cassagneau B; Miquel JP; Puel JP; Mordant B; Kher A; Fauvel JM; Bounhoure JP
Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():113-9. PubMed ID: 3938253
[TBL] [Abstract][Full Text] [Related]
20. [Electrophysiologic effects of betaxolol on conduction properties of the antegrade and retrograde pathway in patients with typical atrioventricular node reentry tachycardia following intravenous and oral administration].
Kühlkamp V; Ickrath O; Haasis R; Seipel L
Z Kardiol; 1988 Aug; 77(8):527-33. PubMed ID: 3176596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
